OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.700
-0.040 (-2.30%)
At close: Mar 28, 2025, 4:00 PM
1.701
+0.001 (0.04%)
After-hours: Mar 28, 2025, 7:57 PM EDT
OPKO Health Revenue
In the year 2024, OPKO Health had annual revenue of $713.14M, down -17.41%. OPKO Health had revenue of $183.64M in the quarter ending December 31, 2024, with 0.95% growth.
Revenue (ttm)
$713.14M
Revenue Growth
-17.41%
P/S Ratio
1.69
Revenue / Employee
$237,952
Employees
2,997
Market Cap
1.14B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 713.14M | -150.35M | -17.41% |
Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
OPK News
- 11 days ago - OPKO and Entera partner to develop obesity pill - Reuters
- 17 days ago - Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses - PRNewsWire
- 4 weeks ago - OPKO Health, Inc. (OPK) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results - GlobeNewsWire
- 2 months ago - OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo - PRNewsWire
- 4 months ago - NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results - PRNewsWire
- 5 months ago - OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha